Whitney Tew
Family Medicine · Huntsville, ALNPI 1205268810
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $95,833 of the $114,197 with a category attached, or 83.9%. CSL Plasma Inc. accounts for 83.9% of it on its own, with 35 other manufacturers making up the rest. Reporting peaked in 2024 at $65,042 and has fallen 76.6% since, to $15,236 in 2025. Among family medicine clinicians in AL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 665 payments — averaging $171.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- CSL Plasma Inc.$96K
- Novo Nordisk$12K
- AbbVie$2K
- Lilly USA, LLC$555
- Amgen$528
- Boehringer Ingelheim$474
- plus $3K from 30 others
What the payments were for
- Consulting fees$95,83384%
- Speaking & faculty fees$9,7279%
- Travel & lodging$2660%
- Food & beverage$8,3727%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| CSL Plasma Inc. | 48 | $95,833 |
| Novo Nordisk | 154 | $12,010 |
| AbbVie(2 entities) | 144 | $1,666 |
| Lilly USA, LLC | 37 | $555 |
| Amgen | 37 | $528 |
| Boehringer Ingelheim | 31 | $474 |
| Takeda Pharmaceuticals U.S.A., Inc. | 21 | $397 |
| Amarin Pharma, Inc. | 26 | $370 |
| AstraZeneca | 21 | $301 |
| Kowa Pharmaceuticals America, Inc. | 22 | $243 |
| Pfizer | 25 | $222 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 17 | $220 |
| Merck | 12 | $188 |
| Johnson & Johnson | 10 | $183 |
| Biohaven Pharmaceutical Holding Company Ltd. | 8 | $153 |
| Sanofi-aventis U.S. LLC | 6 | $98 |
| IBSA Pharma Inc. | 5 | $91 |
| Dexcom, Inc. | 5 | $88 |
| GSK | 5 | $74 |
| Vivus LLC | 4 | $67 |
| Ironwood Pharmaceuticals, Inc | 4 | $55 |
| Bayer | 3 | $52 |
| Daiichi Sankyo Inc. | 3 | $44 |
| Biohaven Pharmaceuticals, Inc. | 2 | $42 |
| Abbott | 2 | $29 |
| Nalpropion Pharmaceuticals LLC | 2 | $29 |
| Axsome Therapeutics, Inc. | 1 | $27 |
| Eisai Inc. | 2 | $26 |
| Astellas Pharma US Inc | 1 | $23 |
| Biogen | 1 | $20 |
| Shire North American Group Inc | 1 | $16 |
| Shield Therapeutics Inc | 1 | $15 |
| Currax Pharmaceuticals LLC | 1 | $15 |
| Genentech USA, Inc. | 1 | $15 |
| Bausch Health US, LLC | 1 | $15 |
| Teva Pharmaceuticals USA, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$114,197 in reported general payments places this provider in the 95th percentile of 1,680 family medicine providers in Alabama.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 11 | $11,568 |
| Gabapentin | 65 | $709 |
| Zolpidem Tartrate | 32 | $202 |
| Tramadol Hcl | 32 | $196 |
| Eszopiclone | 14 | $162 |
| Temazepam | 17 | $89 |
| Clonazepam | 28 | $83 |
| Lorazepam | 16 | $58 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $555 | $11,56811 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,680 family medicine providers in Alabama.
Other family medicine in Huntsville
- Kathleen DupperHuntsville$210K
- Daniel EnglertHuntsville$82K
- Jack EnglertHuntsville$37K
- Tobin FisherHuntsville$33K
- David ShowersHuntsville$18K
- Christopher OhalloranHuntsville$18K
- Michael HoneywellHuntsville$17K
- Prasanna AlladaHuntsville$16K
- Lashelle BarmoreBirmingham$486K
- Regina BenjaminBayou la Batre$222K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.